We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 313 start-ups with an aggregate funding of $6.3b. The average funding per company in this subset is $91.5m.
Last update to the database: Feb 18, 2025. See changelog.
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
5
Funding Rounds
$76.5m
Money raised
Senti Biosciences is a synthetic biology company.
2
Funding Rounds
$158.0m
Money raised
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
5
Funding Rounds
$111.8m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
6
Funding Rounds
$190.5m
Money raised
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
8
Funding Rounds
$117.5m
Money raised
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
5
Funding Rounds
$103.1m
Money raised
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
16
Funding Rounds
$328.8m
Money raised
A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.
1
Funding Rounds
$34.4m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
2
Funding Rounds
$13.8m
Money raised
EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.
1
Funding Rounds
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
6
Funding Rounds
$86.6m
Money raised
Cellink AB is a biotechnology research company based in Gothenburg.
2
Funding Rounds
$4.5m
Money raised
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
9
Funding Rounds
$262.0m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
2
Funding Rounds
$164.5m
Money raised
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
2
Funding Rounds
$67.5m
Money raised
A biotechnology company that develops treatments for cancer and hematologic conditions
2
Funding Rounds
$18.1m
Money raised
A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.
4
Funding Rounds
$743.2m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
3
Funding Rounds
$52.0m
Money raised
Biological micro-pancreas for insulin-dependent diabetics company
4
Funding Rounds
$5.1m
Money raised
Integrated DNA Technologies is a Coralville, Iowa-based company founded in 1987.
1
Funding Rounds
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
3
Funding Rounds
$183.9m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
5
Funding Rounds
$425.0m
Money raised
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
4
Funding Rounds
$46.7m
Money raised
Focused on transforming lives of patients with immune dysfunctions and cancer
2
Funding Rounds
$386.0m
Money raised
Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.
1
Funding Rounds
$5.9m
Money raised
Celdara Medical is a biotechnology company helping turn academic innovations into medical products.
1
Funding Rounds
$1.7m
Money raised
DCPrime is a biotechnology company developing cancer immunotherapies.
5
Funding Rounds
$26.0m
Money raised
Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.
1
Funding Rounds
A biopharmaceutical company developing therapeutics for treating age-related diseases.
3
Funding Rounds
$105.0m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
2
Funding Rounds
$105.0m
Money raised
A biotechnology company developing nucleic acid immunotherapy platform and protein based vaccines
2
Funding Rounds
$60.6m
Money raised
Kiadis Pharma is a biotechnology company developing stem cell regenerative medicine treatments for blood cancers and blood disorders.
1
Funding Rounds
$12.8m
Money raised
Novadip Biosciences is a biotechnology company developing regenerative medicines using stem cells.
2
Funding Rounds
$82.0m
Money raised
A biotechnology company developing t-cell immunotherapies therapies for the treatment of cancer. The company is headquartered in Singapore, and was founded by Malcolm Brenner and Andrew Khoo in 2011.
1
Funding Rounds
$80.0m
Money raised
GentiBio, Inc. is a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology.
2
Funding Rounds
$177.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
1
Funding Rounds
$7.0m
Money raised
Soteria Biotherapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$42.2m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
2
Funding Rounds
$110.0m
Money raised
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage
3
Funding Rounds
$73.4m
Money raised
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.
11
Funding Rounds
$37.9m
Money raised
Locate Bio is a biotechnology developing cell and gene therapies for treating damaged tissues and organs.
9
Funding Rounds
$59.1m
Money raised
Trailhead Biosystems is a biotechnology company developing cell therapy products.
3
Funding Rounds
$17.2m
Money raised
A company developing immune therapies for cancer and related diseases
2
Funding Rounds
$33.8m
Money raised
A Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research.
1
Funding Rounds
$15.0m
Money raised
Gradalis is a drug manufacturer, and developer of vaccines, tools and diagnostics for the treatment of cancer.
1
Funding Rounds
$24.0m
Money raised
Abcuro develops immunotherapies to treat autoimmunity and cancer.
4
Funding Rounds
$72.3m
Money raised
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
2
Funding Rounds
$112.0m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
2
Funding Rounds
$33.9m
Money raised
XEME Biopharma is a biotechnology company developing therapeutic cancer vaccines and cancer immunotherapy products.
2
Funding Rounds
$173.0k
Money raised
AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.
4
Funding Rounds
$6.0m
Money raised
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
1
Funding Rounds
$71.5m
Money raised
TeVido Biodevices is a biotechnology company developing cell therapy products for restoring lost skin pigment.
4
Funding Rounds
$1.4m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
3
Funding Rounds
$200.0m
Money raised
StemBioSys is a biotechnology company developing regenerative medicines using stem cells.
1
Funding Rounds
$1.5m
Money raised
Mogrify is developing tailored cellular conversions that power future cell therapies.
8
Funding Rounds
$84.5m
Money raised
Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.
3
Funding Rounds
$13.2m
Money raised
Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$35.0m
Money raised
Stemedica Cell Technologies is a biopharmaceutical company developing and manufacturing adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies
1
Funding Rounds
$22.0m
Money raised
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.
4
Funding Rounds
$343.1m
Money raised
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.
3
Funding Rounds
$138.0m
Money raised
Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.
4
Funding Rounds
$2.6m
Money raised
Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.
4
Funding Rounds
$193.3m
Money raised
Universal Cells is a biotechnology company developing regenerative medicine using stem cells.
1
Funding Rounds
$60.0k
Money raised
Qihan Biotech is a hangzhou-based biotech company focused on organ transplantation founded in 2017 by Luhan Yang.
1
Funding Rounds
$67.0m
Money raised
Anagenesis Biotechnologies is a biotechnology company developing pre-clinical stem cell therapies for treating genetic and age-related muscle degenerative diseases.
1
Funding Rounds
$3.4m
Money raised
Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.
1
Funding Rounds
$2.5m
Money raised
Macomics is an Edinburgh-based immuno-oncology company.
2
Funding Rounds
$10.0m
Money raised
Aspect Biosystems is a 3D bioprinting founded in 2013 by Tamer Mohamed, Konrad Walus, Sam Wadsworth and Simon Beyer.
1
Funding Rounds
$20.0m
Money raised